No abstract available
MeSH terms
-
Chemotherapy, Adjuvant
-
Disease-Free Survival
-
Humans
-
Imidazoles / therapeutic use
-
Lymph Node Excision / methods*
-
Melanoma / drug therapy
-
Melanoma / pathology
-
Melanoma / surgery*
-
Molecular Targeted Therapy
-
Neoadjuvant Therapy
-
Neoplasm Staging
-
Oximes / therapeutic use
-
Protein Kinase Inhibitors / therapeutic use
-
Proto-Oncogene Proteins B-raf / antagonists & inhibitors
-
Pyridones / therapeutic use
-
Pyrimidinones / therapeutic use
-
Sentinel Lymph Node / pathology*
-
Sentinel Lymph Node Biopsy / methods
-
Skin Neoplasms / drug therapy
-
Skin Neoplasms / pathology
-
Skin Neoplasms / surgery*
-
Survival Rate
-
Tumor Burden
Substances
-
Imidazoles
-
Oximes
-
Protein Kinase Inhibitors
-
Pyridones
-
Pyrimidinones
-
trametinib
-
Proto-Oncogene Proteins B-raf
-
dabrafenib